1. Home
  2. DIN vs NBP Comparison

DIN vs NBP Comparison

Compare DIN & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$36.86

Market Cap

491.1M

ML Signal

HOLD

NBP

NovaBridge Biosciences American Depositary Shares

N/A

Current Price

$3.80

Market Cap

503.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DIN
NBP
Founded
1958
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
491.1M
503.8M
IPO Year
1991
2020

Fundamental Metrics

Financial Performance
Metric
DIN
NBP
Price
$36.86
$3.80
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$30.67
N/A
AVG Volume (30 Days)
455.6K
714.5K
Earning Date
11-05-2025
02-14-2026
Dividend Yield
2.11%
N/A
EPS Growth
N/A
N/A
EPS
2.24
N/A
Revenue
$866,500,000.00
N/A
Revenue This Year
$10.69
N/A
Revenue Next Year
$2.20
N/A
P/E Ratio
$16.12
N/A
Revenue Growth
6.47
N/A
52 Week Low
$18.63
$0.60
52 Week High
$37.24
$6.79

Technical Indicators

Market Signals
Indicator
DIN
NBP
Relative Strength Index (RSI) 67.94 N/A
Support Level $31.26 N/A
Resistance Level $34.22 N/A
Average True Range (ATR) 1.29 0.00
MACD 0.14 0.00
Stochastic Oscillator 92.90 0.00

Price Performance

Historical Comparison
DIN
NBP

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.

Share on Social Networks: